Addtech acquires BioNordika Group

Addtech Life Science, a business area in the Addtech Group, has today acquired
all shares outstanding in BioNordika Holding AB.

BioNordika Holding AB is the parent company of the BioNordika Group, which has
subsidiaries in Denmark, Estonia, Finland, Norway and Sweden. The BioNordika
Group markets reagents and instruments for biomedical research, mainly in the
pharmaceutical industry and at public institutions. The Group has a strong
position in the Nordic market and represents leading suppliers in areas such as
cell and molecular biology as well as immunology and diagnostics. The BioNordika
Group has 24 employees and sales of around SEK 80 million.

The BioNordika Group will very effectively complement Addtech's operations in
the Diagnostic business unit. The business unit focuses on sales of reagents and
equipment for healthcare laboratories in the Nordic region.

The closing will take place today and the acquisition is estimated to have a
marginally positive effect on Addtech's earnings per share during the current
financial year.



Stockholm, 26 January 2012

Addtech AB (publ)


For more information, please contact
Johan Sjö, President, Addtech AB, +46 8 470 49 00
Artur Aira, Business Area Manager, Addtech Life Science, +46 8 54 54 14 00


[HUG#1579952]